je.st
news
McKesson Is On My Radar Screen After Its Most Recent Correction
2015-09-12 12:48:05| Biotech - Topix.net
In the second quarter, the company's adjusted free cash flow was $630M, keeping it on track to generate a massive amount of free cash flow this year. The dividend payments are minimal, and as McKesson doesn't have a lot of long-term debt, I think a share buyback program in 2016 would make sense.
Tags: most
recent
screen
correction
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||